These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3816202)
41. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489 [TBL] [Abstract][Full Text] [Related]
42. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients]. Ambrosioni E Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759 [TBL] [Abstract][Full Text] [Related]
43. Adverse skin reactions to nicotine in a transdermal therapeutic system. Bircher AJ; Howald H; Rufli T Contact Dermatitis; 1991 Oct; 25(4):230-6. PubMed ID: 1839264 [TBL] [Abstract][Full Text] [Related]
44. Sensitization to petrolatum: an unusual cause of false-positive drug patch-tests. Ulrich G; Schmutz JL; Trechot P; Commun N; Barbaud A Allergy; 2004 Sep; 59(9):1006-9. PubMed ID: 15291911 [TBL] [Abstract][Full Text] [Related]
45. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Langley MS; Heel RC Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820 [TBL] [Abstract][Full Text] [Related]
46. New indices in the evaluation of clonidine transdermal therapy of hypertension. de Leonardis V; de Scalzi M; Becucci A; Lusini C; Cinelli P Int J Clin Pharmacol Res; 1989; 9(5):341-5. PubMed ID: 2625373 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring. Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177 [TBL] [Abstract][Full Text] [Related]
48. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm). Jordan WP J Fam Pract; 1992 Jun; 34(6):709-12. PubMed ID: 1593244 [TBL] [Abstract][Full Text] [Related]
49. Transdermal antihypertensive therapy: clinical and metabolic considerations. Weber MA Am Heart J; 1986 Oct; 112(4):906-12. PubMed ID: 2945415 [TBL] [Abstract][Full Text] [Related]
50. Use of transdermal clonidine in chronic hemodialysis patients. Rosansky SJ; Johnson KL; McConnell J Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405 [TBL] [Abstract][Full Text] [Related]
51. Suppressive effects of transdermal clonidine administration on contact hypersensitivity reactions in guinea pigs. Goeptar AR; de Groot J; Lang M; van Tol RG; Scheper RJ Int J Immunopharmacol; 1988; 10(3):277-82. PubMed ID: 3182151 [TBL] [Abstract][Full Text] [Related]
52. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system. Weber MA; Drayer JI Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331 [TBL] [Abstract][Full Text] [Related]
53. Skin sensitivity and transdermal drug delivery. A review of the problem. Carmichael AJ Drug Saf; 1994 Feb; 10(2):151-9. PubMed ID: 8011180 [TBL] [Abstract][Full Text] [Related]
59. Utility of a transdermal delivery system for antihypertensive therapy. Part 1. Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801 [TBL] [Abstract][Full Text] [Related]
60. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. Ishii R; Tagawa T; Ishida T; Naruse T Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]